Avecho Biotechnology Limited (AVE.AX)
AUD 0.0
(-20.0%)
AUD 0.0
(-20.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 97.11 Thousand AUD | -75.84% |
| 2022 | 401.97 Thousand AUD | 104.33% |
| 2021 | 196.73 Thousand AUD | 96.72% |
| 2020 | 100 Thousand AUD | -32.78% |
| 2019 | 148.76 Thousand AUD | 48.99% |
| 2018 | 99.84 Thousand AUD | -65.76% |
| 2017 | 291.64 Thousand AUD | 23.05% |
| 2016 | 237.01 Thousand AUD | -14.74% |
| 2015 | 278 Thousand AUD | 26.36% |
| 2014 | 220 Thousand AUD | -68.53% |
| 2013 | 699 Thousand AUD | -18.15% |
| 2012 | 854 Thousand AUD | -11.41% |
| 2011 | 964 Thousand AUD | 84.67% |
| 2010 | 522 Thousand AUD | 800.0% |
| 2009 | 58 Thousand AUD | -72.64% |
| 2008 | 212 Thousand AUD | 1313.33% |
| 2007 | 15 Thousand AUD | -71.7% |
| 2006 | 53 Thousand AUD | -19.7% |
| 2005 | 66 Thousand AUD | 775.22% |
| 2004 | 7541.00 AUD | 0.0% |
| 2003 | - AUD | -100.0% |
| 2002 | 527.00 AUD | 0.0% |
| 2001 | - AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| 1997 | - AUD | 100.0% |
| 1996 | -189.05 Thousand AUD | 0.0% |
| 1995 | - AUD | 0.0% |
| 1994 | - AUD | 0.0% |
| 1993 | - AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 96.11 Thousand AUD | 0.0% |
| 2023 FY | 97.11 Thousand AUD | -75.84% |
| 2023 Q2 | 135.68 Thousand AUD | 0.0% |
| 2023 Q4 | 97.11 Thousand AUD | 0.0% |
| 2022 Q2 | 475.6 Thousand AUD | 0.0% |
| 2022 FY | 401.97 Thousand AUD | 104.33% |
| 2022 Q4 | 401.97 Thousand AUD | 0.0% |
| 2021 Q4 | 196.73 Thousand AUD | 0.0% |
| 2021 FY | 196.73 Thousand AUD | 96.72% |
| 2021 Q2 | 164.38 Thousand AUD | 0.0% |
| 2020 Q2 | 140.26 Thousand AUD | 0.0% |
| 2020 FY | 100 Thousand AUD | -32.78% |
| 2020 Q4 | 100 Thousand AUD | 0.0% |
| 2019 Q4 | 148.76 Thousand AUD | 0.0% |
| 2019 FY | 148.76 Thousand AUD | 48.99% |
| 2019 Q2 | 90.84 Thousand AUD | 0.0% |
| 2018 Q2 | 310.33 Thousand AUD | 0.0% |
| 2018 FY | 99.84 Thousand AUD | -65.76% |
| 2018 Q4 | 99.84 Thousand AUD | 0.0% |
| 2017 Q4 | 291.64 Thousand AUD | 0.0% |
| 2017 FY | 291.64 Thousand AUD | 23.05% |
| 2017 Q2 | 165.46 Thousand AUD | 0.0% |
| 2016 Q2 | 302 Thousand AUD | 0.0% |
| 2016 Q4 | 237.01 Thousand AUD | 0.0% |
| 2016 FY | 237.01 Thousand AUD | -14.74% |
| 2015 FY | 278 Thousand AUD | 26.36% |
| 2015 Q2 | 201 Thousand AUD | 0.0% |
| 2015 Q4 | 278 Thousand AUD | 0.0% |
| 2014 FY | 220 Thousand AUD | -68.53% |
| 2014 Q2 | 770 Thousand AUD | 0.0% |
| 2014 Q4 | 220 Thousand AUD | 0.0% |
| 2013 Q2 | 761 Thousand AUD | 0.0% |
| 2013 FY | 699 Thousand AUD | -18.15% |
| 2013 Q4 | 699 Thousand AUD | 0.0% |
| 2012 Q4 | 854 Thousand AUD | 0.0% |
| 2012 FY | 854 Thousand AUD | -11.41% |
| 2011 FY | 964 Thousand AUD | 84.67% |
| 2011 Q4 | 964 Thousand AUD | 0.0% |
| 2010 Q4 | 522 Thousand AUD | 0.0% |
| 2010 FY | 522 Thousand AUD | 800.0% |
| 2009 Q4 | 58 Thousand AUD | 0.0% |
| 2009 FY | 58 Thousand AUD | -72.64% |
| 2008 FY | 212 Thousand AUD | 1313.33% |
| 2008 Q4 | 212 Thousand AUD | 0.0% |
| 2007 Q4 | 15 Thousand AUD | 0.0% |
| 2007 FY | 15 Thousand AUD | -71.7% |
| 2006 Q4 | 53 Thousand AUD | 0.0% |
| 2006 FY | 53 Thousand AUD | -19.7% |
| 2005 FY | 66 Thousand AUD | 775.22% |
| 2005 Q4 | 66 Thousand AUD | 0.0% |
| 2004 Q4 | 7541.00 AUD | 0.0% |
| 2004 FY | 7541.00 AUD | 0.0% |
| 2003 FY | - AUD | -100.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2002 FY | 527.00 AUD | 0.0% |
| 2002 Q4 | - AUD | 0.0% |
| 2001 Q4 | - AUD | 0.0% |
| 2001 FY | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| 1998 Q4 | - AUD | 0.0% |
| 1997 Q4 | - AUD | 0.0% |
| 1997 FY | - AUD | 100.0% |
| 1996 FY | -189.05 Thousand AUD | 0.0% |
| 1995 FY | - AUD | 0.0% |
| 1994 FY | - AUD | 0.0% |
| 1993 FY | - AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AdAlta Limited | -1.67 Million AUD | 105.782% |
| Biome Australia Limited | 1.88 Million AUD | 94.858% |
| Radiopharm Theranostics Limited | -987.41 Thousand AUD | 109.835% |
| Biotron Limited | - AUD | -Infinity% |
| Acrux Limited | 147 Thousand AUD | 33.934% |
| Alterity Therapeutics Limited | 1.00 AUD | -9711600.0% |
| Botanix Pharmaceuticals Limited | 1.2 Million AUD | 91.97% |
| BTC Health Limited | - AUD | -Infinity% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 8.93 Billion AUD | 99.999% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | 99.086% |
| Immutep Limited | 2.00 AUD | -4855750.0% |
| Memphasys Limited | 164.76 Thousand AUD | 41.056% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Noxopharm Limited | -2.35 Million AUD | 104.116% |
| Prescient Therapeutics Limited | - AUD | -Infinity% |
| Race Oncology Limited | 16.4 Thousand AUD | -492.141% |
| Starpharma Holdings Limited | 2.4 Million AUD | 95.967% |
| Tissue Repair Ltd | 214.72 Thousand AUD | 54.771% |
| EZZ Life Science Holdings Limited | 1.4 Million AUD | 93.069% |
| Anatara Lifesciences Ltd | -671.09 Thousand AUD | 114.471% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 1.25 Million AUD | 92.245% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 1.17 Million AUD | 91.746% |
| Imugene Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | -17.99 Million AUD | 100.54% |
| Proteomics International Laboratories Limited | - AUD | -Infinity% |
| Cynata Therapeutics Limited | 108.2 Thousand AUD | 10.246% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Nanollose Limited | - AUD | -Infinity% |
| Invex Therapeutics Ltd | -94.98 Thousand AUD | 202.247% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | -877.24 Thousand AUD | 111.071% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.31 Million AUD | 99.439% |
| Dimerix Limited | - AUD | -Infinity% |
| PharmAust Limited | - AUD | -Infinity% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 221.85 Thousand AUD | 56.225% |
| Paradigm Biopharmaceuticals Limited | - AUD | -Infinity% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Actinogen Medical Limited | 108.82 Thousand AUD | 10.762% |
| Immuron Limited | 1.58 Million AUD | 93.871% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |